Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Horsfall

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1995
Androgens induce divergent proliferative responses in human breast cancer cell linesS N Birrell, J M Bentel, T E Hickey, et al.
The Journal of Urology|July 2, 1998
Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancersS X Zhang, J M Bentel, C Ricciardelli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1994
Age-related changes in guinea pig prostatic stromaD J Horsfall, K Mayne, C Ricciardelli, et al.
British Journal of Cancer|October 1, 1996
Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancerR E Hall, J O Aspinall, D J Horsfall, et al.
International Journal of Cancer|January 2, 1994
The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study GroupR Seshadri, D J Horsfall, F Firgaira, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancerC Ricciardelli, K Mayne, P J Sykes, et al.
The Prostate|January 13, 2004
Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancerR E Hall, D J Horsfall, J Stahl, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Identification of the major sources of error in estrogen receptor measurements for individual laboratories using both tissue and cytosol samplesB W Borjesson, M N Cauchi, P J Compton, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Sources of improvement in between laboratory variation in estrogen and progestin receptor measurement using tissue samples during the Australian Quality Assurance ProgrammeB W Borjesson, M N Cauchi, P J Compton, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1995
Androgens induce divergent proliferative responses in human breast cancer cell linesS N Birrell, J M Bentel, T E Hickey, et al.
The Journal of Urology|July 2, 1998
Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancersS X Zhang, J M Bentel, C Ricciardelli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1994
Age-related changes in guinea pig prostatic stromaD J Horsfall, K Mayne, C Ricciardelli, et al.
British Journal of Cancer|October 1, 1996
Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancerR E Hall, J O Aspinall, D J Horsfall, et al.
International Journal of Cancer|January 2, 1994
The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study GroupR Seshadri, D J Horsfall, F Firgaira, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancerC Ricciardelli, K Mayne, P J Sykes, et al.
The Prostate|January 13, 2004
Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancerR E Hall, D J Horsfall, J Stahl, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Identification of the major sources of error in estrogen receptor measurements for individual laboratories using both tissue and cytosol samplesB W Borjesson, M N Cauchi, P J Compton, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Sources of improvement in between laboratory variation in estrogen and progestin receptor measurement using tissue samples during the Australian Quality Assurance ProgrammeB W Borjesson, M N Cauchi, P J Compton, et al.
Pageof 6